logo

Xencor Inc (XNCR)



Trade XNCR now with
  Date
  Headline
2/26/2018 8:15:01 AM Xencor Signs 4 Commercial License Deals With Selexis SA To Advance Pipeline Of XmAb Bispecific Antibody Drug Candidates
2/22/2018 8:05:36 AM Xencor Doses First Patient In Phase 1 Study Of XmAb 18087 Bispecific Tumor Targeting Antibody
12/18/2017 12:11:29 PM Wedbush Is Raising Xencor Inc (XNCR) FY17 Estimate To -0.85 From -1.06
12/18/2017 12:11:11 PM Wedbush Is Increasing Xencor Inc (XNCR) Q4 17 Estimate To -0.06 From -0.27
12/5/2017 8:03:37 AM Xencor Earns $10 Mln Milestone Payment From Amgen
11/8/2017 1:10:10 PM Wedbush Is Increasing Xencor Inc (XNCR) FY17 Rev. Estimate To 35.8 M From 34.7 M
11/8/2017 1:09:28 PM Wedbush Is Lowering Xencor Inc (XNCR) FY18 Estimate To -1.83 From -1.71
11/8/2017 1:09:06 PM Wedbush Is Cutting Xencor Inc (XNCR) FY17 Estimate To -1.06 From -1.02
11/8/2017 1:08:50 PM Wedbush Is Lowering Xencor Inc (XNCR) Q4 17 Estimate To -0.27 From -0.24
6/16/2017 1:50:28 PM Wedbush Reiterates Xencor Inc (XNCR) At Outperform With $29.00 Price Target
6/6/2017 1:51:58 PM Wedbush Reiterates Xencor Inc (XNCR) At Outperform With $29 Price Target
5/11/2017 8:03:34 AM Xencor Says XmAb5871 Gets Orphan Drug Designation From FDA For Treatment Of IgG4-Related Disease
5/10/2017 8:45:40 AM Wedbush Reiterates Xencor Inc (XNCR) At Outperform With $29 Price Target
5/10/2017 8:45:09 AM Wedbush Is Cutting Xencor Inc (XNCR) 2018 Estimate To -1.70 From -1.44